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Abstract
Background—The melanocortin (MC) system is composed of peptides that are cleaved from the
polypeptide precursor, pro-opiomelanocortin (POMC). Previous research has shown that MC
receptor (MCR) agonists reduce, and MCR antagonists increase, ethanol consumption in rats and
mice. Consistently, genetic deletion of the endogenous MCR antagonist, agouti-related protein
(AgRP), causes reductions of ethanol-reinforced lever pressing and binge-like ethanol drinking in
C57BL/6J mice. Ethanol also has direct effects on the central MC system, as chronic exposure to
an ethanol-containing diet causes significant reductions of α-melanocyte stimulating hormone (α-
MSH) immunoreactivity in specific brain regions of Sprague-Dawley rats. Together, these
observations suggest that the central MC system modulates neurobiological responses to ethanol.
To further characterize the role of the MC system in responses to ethanol, here we compared
AgRP and α-MSH immunoreactivity in response to an acute injection of saline or ethanol between
high ethanol drinking C57BL/6J mice and moderate ethanol drinking 129/SvJ mice.
Methods—Mice received an intraperitoneal (i.p.) injection of ethanol (1.5 g/kg or 3.5 g/kg;
mixed in 0.9% saline) or an equivolume of 0.9% saline. Two hours after injection, animals were
sacrificed and their brains were processed for AgRP and α-MSH immunoreactivity.
Results—Results indicated that acute ethanol administration triggered a dose-dependent increase
in AgRP immunoreactivity in the arcuate (ARC) of C57BL/6J mice, an effect that was not evident
in the 129/SvJ strain. Although acute administration of ethanol did not influence α-MSH
immunoreactivity, C57BL/6J mice had significantly greater overall α-MSH immunoreactivity in
the ARC, dorsomedial, and lateral regions of the hypothalamus relative to the 129/SvJ strain. In
contrast, C57BL/6J mice displayed significantly lower α-MSH immunoreactivity in the medial
amygdala.
Conclusions—The results show that acute ethanol exposure has direct effects on endogenous
AgRP activity in ethanol preferring C57BL/6J mice. It is suggested that ethanol-induced increases
in AgRP may be part of a positive feedback system that stimulates excessive binge-like ethanol
drinking in C57BL/6J mice. Inherent differences in α-MSH immunoreactivity may contribute to
differences in neurobiological responses to ethanol that are characteristically observed between the
C57BL/6J and 129/SvJ inbred strains of mice.
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THE MELANOCORTIN (MC) system is composed of peptides that are cleaved from the
polypeptide precursor pro-opiomelanocortin (POMC). Central MC peptides are produced by
neurons within the hypothalamic arcuate (ARC) nucleus and the medulla (Dores et al., 1986;
Jacobowitz and O'Donohue, 1978; O'Donohue and Dorsa, 1982), and include
adrenocorticotropic hormone, α-melanocyte stimulating hormone (α-MSH), β-MSH, and γ-
MSH (Hadley and Haskell-Luevano, 1999). Due to a lack of a critical dibasic site, β-MSH is
not processed in rodent brain (Pritchard et al., 2002). In rodents, MC peptides act through 5
MC receptors (MC1R to MC5R) (Hadley and Haskell-Luevano, 1999). The MC3R and
MC4R are the primary MC receptors (MCR) expressed in the rodent brain (Alvaro et al.,
1997). Agoutirelated protein (AgRP), a neuropeptide produced in the hypothalamus and co-
secreted with neuropeptide Y in the same synaptic complexes as α-MSH functions as a
natural MCR antagonist (Shutter et al., 1997). More recent in vivo evidence suggests that
AgRP may function as a MCR inverse agonist (Tolle and Low, 2008).
β-endorphin, an opioid peptide that is also cleaved from POMC and is co-expressed with α-
MSH in the brain (Bloch et al., 1979), modulates neurobiological responses to ethanol
(Froehlich and Li, 1993; Gianoulakis, 2001; Rasmussen et al., 2002; Scanlon et al., 1992;
Zhou et al., 2000) and opioid receptor antagonists reduce ethanol consumption (Gianoulakis,
2001). Interestingly, there appear to be a functional interaction between MC and opioid
neuropeptides. For example, stimulation of MCRs block the antinociceptive effects of
opioids, whereas MC4R antagonists enhance opioid antinociception (Ercil et al., 2005). It is
therefore not surprising that evidence has emerged suggesting that MC neuropeptides also
modulate neurobiological responses to ethanol. First, α-MSH is expressed in brain regions
implicated in ethanol's effects, including the striatum, nucleus accumbens (NAc), ventral
teg-mental area (VTA), amygdala, hippocampus, and hypothalamus (Bloch et al., 1979;
Dube et al., 1978; Jacobowitz and O'Donohue, 1978; O'Donohue and Jacobowitz, 1980;
O'Donohue et al., 1979; Yamazoe et al., 1984). Second, rats selectively bred for high ethanol
drinking (AA [Alko, Alcohol]) have low levels of MC3R in the shell of the NAc, but have
high levels of MC3R and MC4R in various regions of the hypothalamus, when compared
with low ethanol-drinking rats (Lindblom et al., 2002). Third, central infusion of the
nonselective MCR agonist, melanotan-II (MTII) significantly reduced voluntary ethanol
drinking in AA rats with an established history of ethanol intake (Ploj et al., 2002).
Similarly, MTII-induced reduction of ethanol consumption was shown to be receptor-
mediated and not associated with alterations of ethanol metabolism in C57BL/6J mice
(Navarro et al., 2003). More recently, ventricular infusion of a selective MC4R agonist
significantly reduced ethanol drinking, whereas ventricular infusion of the nonselective
MCR antagonist AgRP-(83 to 132) significantly increased ethanol drinking, by C57BL/6J
mice (Navarro et al., 2005). Consistent with pharmacological data, genetic deletion of
endogenous AgRP reduced ethanol-reinforced lever pressing and binge-like ethanol drinking
in C57BL/6J (Navarro et al., 2009). Ethanol also has direct effects on central MC activity.
Thus, chronic exposure to ethanol significantly reduced (Navarro et al., 2008), while
abstinence following chronic ethanol exposure increased (Kokare et al., 2008), endogenous
α-MSH immunoreactivity in specific brain regions of Sprague-Dawley rats.
The objective of this study was to further characterize the roles of endogenous AgRP and α-
MSH in the modulation of neurobiological responses to ethanol. Many genetically altered
mouse lines, including MC3R-, MC4R-, and AgRP-deficient mice (Marsh et al., 1999;
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Navarro et al., 2005, 2009), were originally derived on a hybrid genetic background of the
C57BL/6J inbred strain and 1 of the 129 substrains. Thus, assessing differences in AgRP
and α-MSH immunoreactivity between the C57BL/6J and a 129 strain would provide
valuable informative for studies that examine ethanol-related phenotypes in MCR or AgRP
knockout mice, or in other knockout mice which entail mutations that interact with the MC
system. Furthermore, comparisons of inbred strains of mice is a useful first-step approach to
identify neurochemical pathways that may modulate neurobiological responses to ethanol
and ethanol intake (Bachtell et al., 2002; Hayes et al., 2005; Weitemier et al., 2005). Thus,
here we compared brain AgRP and α-MSH immunoreactivity between C57BL/6J and 129/
SvJ mice inbred strains that have been shown to exhibit different levels of ethanol
consumption. C57BL/6J mice voluntarily consume 10 g/kg/d to 12 g/kg/d of ethanol when
offered a 10% (v/v) solution, while mice of the 129/SvJ strain consumes about half as much,
or 5 g/kg/d to 6 g/kg/d of 10% ethanol (Belknap et al., 1993). Based on previous
pharmacological and genetic observations, we predicted that these inbred strains would
show differences in baseline and ethanol-induced AgRP and α-MSH immunoreactivity in
brain region implicated in neurobiological responses to ethanol.
MATERIALS AND METHODS
Animals
Male 129/SvJ and C57BL/6J inbred strains of mice (Jackson Laboratories, Bar Harbor, ME)
weighed approximately 20 g to 25 g and were 6 to 8 weeks of age upon arrival. Mice were
individually housed in polypropylene cages with wood-chip bedding and had ad libitum
access to standard rodent chow (Teklad, Madison, WI) and water throughout the experiment.
The colony room was maintained at approximately 22°C with a 12 hours:12 hours,
light:dark cycle. All procedures used in this study were in compliance with the National
Institute of Health guidelines, and all protocols were approved by the University of North
Carolina Institutional Animal Care and Use Committee. Body weight (g), water (ml/kg/24
h), and food (g/kg/24 h) consumption were collected for 1 week prior to the experiment and
average baseline measures were calculated for each strain of inbred mice.
Acute Ethanol Administration
On the test day, mice were weighed, and water and food were removed from each cage.
Then, mice were divided into 3 groups based on body weight, and given a single
intraperitoneal (i.p.) injection of ethanol (1.5 g/kg or 3.5 g/kg, 7.5 ml/kg and 17.5 ml/kg,
respectively; 20% [w/v] mixed in 0.9% saline) or an equivolume of 0.9% saline (17.5 ml/
kg). Mice were then returned to their homecage immediately after the injection where they
remained until perfusion procedures. As α-MSH and AgRP have been implicated in feeding
behaviors (Sainsbury et al., 2002), procedures were carried out during the animals' light
cycle, a time of day in which feeding behavior in mice is low. Injections began 2 hours into
the light cycle, and were staggered (counterbalanced by strain and injection condition) so
that all mice were perfused exactly 2 hours after injection. Another set of naive C57BL/6J
and 129/SvJ mice were given i.p. injection of a 1.5 g/kg or 3.5 g/kg dose of ethanol, and
blood samples were collected 2 hours later to assure that ethanol-induced differences in
immunohistochemistry (IHC) between strains were not associated with strain differences in
blood ethanol concentrations (BECs). Approximately 10 μl of blood was collected from the
tail vein of each mouse, samples were centrifuged, and 5 μl of plasma from each sample was
analyzed for BECs measured in mg/dl (Analox Instruments, Lunenburg, MA).
Perfusions, Brain Preparation, and Immunohistochemistry
Two hours after ethanol or saline injection, mice were injected with a cocktail of ketamine
(117 mg/kg) and xylazine (7.92 mg/kg) and then transcardially perfused for 10 minutes with
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0.1 mM phosphate-buffered saline (PBS; pH 7.4) followed by 4% paraformaldehyde in
phosphate buffer. The 2 hours postinjection perfusion time was chosen because we have
previously found treatment-induced differences in protein at this time interval (Thiele et al.,
1997, 1998a, 2000). All perfusions were completed within a 5-hour window of time. The
brains were collected and postfixed in paraformaldehyde for 24 hours at 4°C, at which point
they were transferred to PBS. Brains were cut using a vibrotome into 40 μm sections and
were then stored in PBS. IHC procedures were based on those routinely used in our
laboratory (Hayes et al., 2005; Thiele et al., 1996, 1997, 1998a,b, 2000). Sections were
evenly divided into 2 sets (every-other section) for processing with α-MSH or AgRP
antibodies. After rinsing in fresh PBS 4 times (10 minutes each), tissue sections were
blocked in 10% rabbit serum (for α-MSH) or 10% goat serum (for AgRP) and 0.1% triton-
X-100 in PBS for 1 hour. Sections were then transferred to fresh PBS containing primary
sheep anti-α-MSH (Millipore, Billerica, MA; 1:10,000) or primary rabbit anti-AgRP
(Phoenix Pharmaceuticals, Inc., Burlingame, CA; 1:4,000) for 3 days at 4°C. As a control to
determine if staining required the presence of the primary antibodies, some sections were
run through the assay without primary antibody (α-MSH or AgRP). In each assay described
below, tissue processed without the primary antibody failed to show staining that was
evident in tissue processed with primary antibody. After the 3 days of incubation, the
sections were rinsed 4 times and then processed with Vectastain Elite kits (Vector Labs,
Burlingame, CA) as per the manufacturer's instructions for standard ABC/HRP/
diaminobenzidinebased IHC. The sections processed for α-MSH or AgRP were visualized
by reacting the sections with a 3,3-diaminobenzidine tetrahydrochloride (DAB;
Polysciences, Inc., Warrington, MA) reaction solution containing 0.05% DAB, 0.005%
cobalt, 0.007% nickel ammonium sulfate, and 0.006% hydrogen peroxide. All sections were
mounted on glass slides, air-dried overnight, and cover slipped for viewing. Digital images
of α-MSH and AgRP IHC were obtained on a Nikon E400 microscope equipped with a
Nikon Digital Sight DS-U1 digital camera run with Nikon-provided software. For analysis,
great care was taken to match sections through the same region of brain and at the same
level using anatomic landmarks with the aid of a mouse stereotaxic atlas (Franklin and
Paxinos, 1997). Densitometric procedures were used to assess protein levels. Flat-field
corrected digital pictures (8-bit grayscale) were taken using the Digital Sight DS-U1 camera
and density of staining was analyzed using Image J software (Image J; National Institute of
Health, Bethesda, MD) by calculating the percent of the total area examined that showed
signal (cell bodies and processes) relative to a subthreshold background. The size of the
areas that were analyzed was the same between animals and groups. The subthreshold level
for the images was set in such a way that any area without an experimenter-defined level of
staining (determined by terminal- and/or soma-positive regions) was given a value of zero.
Within each region, the same subthreshold level was used for each slice that was scored.
Data from each brain region in an animal were calculated by taking the average counts from
2 brain slices. Data from each slice were calculated by taking the average counts from the
left and right sides of the brain at the specific brain region of interest. For each brain region,
photographs were taken at approximately the medial area of the structure (with respect to the
rostral-caudal axis) for each of the 2 brain slices that were scored. In all cases, quantification
of IHC data was conducted by an experimenter that was blinded to group identity. We
quantified α-MSH immunoreactivity in regions of the hypothalamus (the ARC, dorsomedial
[DMH], and lateral [LH] regions) and the medial amygdala (MA) regions in which we found
robust α-MSH staining and which have been implicated in neurobiological responses to
ethanol and other drugs of abuse (Aston-Jones et al., 2009; Cannella et al., 2009; DiLeone et
al., 2003; Doron et al., 2006; Harris and Aston-Jones, 2006; Hunt and McGregor, 1998;
Koob, 2003). Consistent with our previous findings (Navarro et al., 2008), AgRP
immunoreactivity was observed primarily in the ARC.
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All data collected in this study are presented as mean ± SEM and differences between
groups were analyzed using analysis of variance (ANOVA). One-way ANOVAs were
performed on baseline body weight, food intake, and water consumption data. Independent
twoway, 2 × 3 (strain × dose) ANOVAs were performed on IHC data collected from each
brain region and on BEC data. Sample sizes vary in IHC analyses below as appropriate
representative sections through target brain regions were not available in some cases. When
significant main effects or interactions were found, post hoc analyses were conducted using
Newman–Keuls tests. To control for the increased likelihood of Type 1 errors with multiple
comparisons, the level of significance was set at p < 0.0125 for analyses involving α-MSH
immunoreactivity data in the 4 brain regions examined, consistent with a Bonferroni
correction. For all other analyses, the level of significance was set at p <0.05.
RESULTS
Strain Comparisons of Body Weight, Food and Water Intake, and Blood Ethanol Levels
Because α-MSH and AgRP have been implicated in food intake and body weight regulation
(Sainsbury et al., 2002), we determined if there were differences between C57BL/6J and
129/SvJ mice in body weight, food intake, and water drinking. The C57BL/6J mice (n = 25)
and 129/SvJ mice (n = 25) did not differ significantly in average body weight ([F(1, 48) =
0.2, p > 0.05]; 20.6 ± 0.14 g and 20.4 ± 0.14 g, respectively), food intake ([F(1, 48) = 0.4, p
>0.05]; 4.5 ± 0.14 g/d and 4.6 ± 0.14 g/d, respectively), or water drinking [F(1, 48) = 0.2, p
> 0.05]; 5.2 ± 0.14 ml/d and 5.1 ± 0.14 ml/d, respectively). Additionally, C57BL/6J (n = 7
per dose condition) and 129/SvJ (n = 6 or 7 for the 1.5 g/kg and 3.5 g/kg doses of ethanol,
respectively) mice did not differ significantly in BECs 2 hours following injection of a 1.5 g/
kg (51.11 ± 4.48 mg/dl and 71.03 ± 4.49 mg/dl, respectively) or a 3.5 g/kg (273.12 ± 3.51
mg/dl and 277.96 ± 16.36 mg/dl, respectively) dose of ethanol. A two-way ANOVA
performed on BEC data showed a significant main effect of ethanol dose [F(1, 23) = 538.02,
p < 0.05] but neither the strain main effect [F(1, 23) = 1.79, p > 0.05] nor interaction effect
[F(1, 23) = 0.66, p > 0.05] were statistically significant.
AgRP IHC in the Arcuate Nucleus Following Saline or Ethanol Injection
Figure 1 shows data representing the average densities of AgRP immunoreactivity in the
ARC of 129/SvJ and C57BL/6J mice given i.p. injection of saline (n = 6 and 4,
respectively), a 1.5 g/kg dose of ethanol (n = 7 and 4, respectively) or a 3.5 g/kg dose of
ethanol (n = 5 and 7, respectively), and representative photomicrographs of AgRP
immunoreactivity in the ARC of 129/SvJ and C57BL/6J mice are presented in Fig. 2. A two-
way ANOVA performed on this data set showed a statistically significant main effect of
mouse strain [F(1, 27) = 14.15, p < 0.05] and a significant dose × mouse strain interaction
[F(2, 27) = 5.0, p < 0.05], but the dose main effect was not statistically significant [F(1, 27)
= 1.5, p > 0.05]. Post hoc Newman-Keuls tests showed that C57BL/6J mice exhibited a
dose-dependent increase in AgRP immunoreactivity that was not evident in 129/SvJ mice.
α-MSH IHC in Regions of the Hypothalamus and MA Following Saline or Ethanol Injection
Arcuate Nucleus—Figure 3A shows data representing the average densities of α-MSH
immunoreactivity in the ARC of 129/SvJ and C57BL/6J mice given i.p. injection of saline
(n = 4/strain), a 1.5 g/kg dose of ethanol (n = 8 and 5, respectively) or a 3.5 g/kg dose of
ethanol (n = 6 and 7, respectively), and representative photomicrographs of α-MSH
immunoreactivity in the ARC of 129/SvJ and C57BL/6J mice are presented in Fig. 4A,E,
respectively. A two-way ANOVA performed on these data revealed a significant main effect
of mouse strain [F(1, 28) = 7.4, p < 0.0125]. Neither the dose effect [F(2,28) = 0.6, p >
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0.0125] nor the dose × strain interaction [F(2, 28) = 0.4, p > 0.0125] attained statistical
significance.
Lateral Hypothalamus—Figure 3B shows data representing the average densities of α-
MSH immunoreactivity in the LH of 129/SvJ and C57BL/6J mice given i.p. injection of
saline (n = 8/strain), a 1.5 g/kg dose of ethanol (n = 8/strain) or a 3.5 g/kg dose of ethanol (n
= 8 and 9, respectively), and representative photomicrographs of α-MSH immunoreactivity
in the LH of 129/SvJ and C57BL/6J mice are presented in Fig. 4B,F, respectively. A two-
way ANOVA performed on this data set showed a significant main effect of mouse strains
[F(1, 43) = 39.2, p < 0.0125]. The dose main effect [F(2, 43) = 0.4, p > 0.0125] and the
interaction effect [F(2, 43) = 0.7, p > 0.0125] were not statistically significant.
Dorsomedial Hypothalamus—Figure 3C shows data representing the average densities
of α-MSH immunoreactivity in the DMH of 129/SvJ and C57BL/6J mice given i.p. injection
of saline (n =7/strain), a 1.5 g/kg dose of ethanol (n = 6 and 8, respectively) or a 3.5 g/kg
dose of ethanol (n = 7 and 8, respectively), and representative photomicrographs of α-MSH
immunoreactivity in the DMH of 129/SvJ and C57BL/6J mice are presented in Fig. 4C,G,
respectively. A two-way ANOVA performed on these data showed a statistically significant
main effect of mouse strains [F(1, 37) = 10.7, p < 0.0125], but neither the dose [F(2, 37) =
0.7, p > 0.0125] nor the interaction [F(2, 37) = 0.8, p > 0.0125] effects were statistically
significant. Taken together, these results show that hypothalamic α-MSH immunoreactivity
is significantly higher in the C57BL/6J strain relative to 129/SvJ strain of mice.
Immunoreactivity of α-MSH in the MA—Figure 3D shows data representing the
average densities of α-MSH immunoreactivity in the MA of 129/SvJ and C57BL/6J given
i.p. injection of saline (n = 8/strain), a 1.5 g/kg dose of ethanol (n = 8/strain) or a 3.5 g/kg
dose of ethanol (n = 9/strain), and representative photomicrographs of α-MSH
immunoreactivity in the MA of 129/SvJ and C57BL/6J mice are presented in Fig. 4D,H,
respectively. As above, a two-way ANOVA performed on these data revealed a significant
main effect of mouse strain [F(1, 44) = 7.85, p < 0.0125], but neither the dose [F(2, 44) =
1.9, p > 0.0125] nor interaction [F(2, 44) = 0.2, p > 0.0125] effects achieved statistical
significance. In contrast to the hypothalamic regions examined, α-MSH immunoreactivity in
the MA was significantly lower in C57BL/6J mice relative to 129/SvJ mice.
DISCUSSION
The most important observation is the present work is that acute administration of a 3.5 g/kg
dose of ethanol caused a significant increase in AgRP immunoreactivity in the ARC of
C57BL/6J mice, an effect that was not evident in 129/SvJ mice. Strain differences in AgRP
immunoreactivity are not likely secondary to strain differences in ethanol metabolism as
C57BL/6J and 129/SvJ mice showed similar BECs 2 hours following injection of a 3.5 g/kg
dose of ethanol. Additionally, since there were no strain differences in body weight, absolute
dosing volume is also not an explanation for strain differences in ethanol-induced AgRP
immunoreactivity. Since AgRP plays a role in the modulation of caloric intake, it might be
argued that the extra calories associated with ethanol administration were the cause of
increased AgRP immunoreactivity in mice injected with the 3.5 g/kg dose. However,
reduced caloric intake stemming from fasting is associated with increased AgRP
immunoreactivity in the hypothalamus of rats, mice, and sheep (Dunbar et al., 2005;
Fetissov et al., 2005; Wagner et al., 2004). In contrast, increasing caloric load (Chang et al.,
2005; Ziotopoulou et al., 2000) and hyperphagia in obese tub/tub mice (Backberg et al.,
2004) are associated with decreased AgRP expression. Taken together, these previous
findings make it unlikely that increased AgRP immunoreactivity in the present report was
caused by the calories inherent in ethanol.
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With IHC procedures, increased immunoreactivity in response to ethanol exposure could
indicate that ethanol facilitates normal signaling via increased production of AgRP.
Alternatively, ethanol-induced increases of AgRP immunoreactivity could reflect blunted
AgRP signaling, via an attenuation of release and/or augmentation of AgRP re-uptake into
presynaptic terminals. While either ethanol-induced increases or decreases in AgRP
signaling are possible, the most significant observation in the present work is that ethanol
appears to have direct affects on central AgRP activity. This being said, based on previous
observations that have implicated AgRP signaling in the modulation of ethanol
consumption, we suggest that ethanol-induced increases of AgRP immunoreactivity likely
reflect an increase of AgRP signaling. First, central infusion of the AgRP-(83 to 132)
fragment increases (Navarro et al., 2005), while genetic deletion of AgRP reduces (Navarro
et al., 2009), ethanol self-administration by C57BL/6J mice. Second, C57BL/6J mice show
twice the level of ethanol drinking relative to 129/SvJ mice when offered a 10% ethanol
solution (Belknap et al., 1993) and here we found that only C57BL/6J mice showed ethanol-
induced increases of AgRP. While it is not completely clear if ethanol drinking promotes
increases of AgRP immunoreactivity in C57BL/6J mice or if ethanol-induced AgRP
immunoreactivity contributes to the high level of ethanol drinking characteristic of this
strain, an interesting possibility is that ethanol-induced increase of AgRP signaling is part of
mechanism that involves a positive feedback loop, such that ethanol intake stimulates AgRP
which in turn promotes further excessive binge-like drinking. In fact, AgRP
immunoreactivity has been identified in brain regions implicated in ethanol consumption,
including the VTA, NAc, amygdala, bed nucleus of the stria terminalis, and lateral septum
(Bagnol et al., 1999), and we have recently shown that AgRP positively modulates binge-
like ethanol drinking in C57BL/6J mice (Navarro et al., 2009). Such a positive feedback
loop has also been proposed for the neuropeptide galanin. As with AgRP, ethanol stimulates
hypothalamic galanin activity and central galanin administration promotes ethanol
consumption (Lewis et al., 2005; Schneider et al., 2007). It will be important in future work
to determine if C57BL/6J mice show increased AgRP immunoreactivity following a bout of
binge-like ethanol drinking. It should be noted that because C57BL/6J and 129/SvJ mice
have also been reported to show differences in other ethanol-related phenotypes, such as
ethanol-induced sedation (Homanics et al., 1999), AgRP signaling may be involved with any
number of neurobiological responses to ethanol that differ between these strains.
The second observation of interest in the present report is that there were region-specific
differences in α-MSH immunoreactivity between strains with C57BL/6J mice showing
significantly higher α-MSH immunoreactivity in regions of the hypothalamus and lower α-
MSH immunoreactivity in the MA relative to 129/SvJ mice. Additionally, the significant
main effect of mouse strain in AgRP immunoreactivity indicates that C57BL/6J mice also
display a general increase of AgRP in the ARC when compared with 129/SvJ mice. While
α-MSH and AgRP have been implicated in food intake and body weight regulation
(Sainsbury et al., 2002), the present observations that C57BL/6J and 129/SvJ mice showed
statistically similar food intake and body weight suggests that strain differences in α-MSH
and AgRP immunoreactivity are not likely related to strain differences in feeding and energy
homeostasis. Because C57BL/6J mice drink on average twice as much 10% ethanol as 129/
SvJ mice (Belknap et al., 1993) and are less sensitive to the sedative/hypnotic effects of
ethanol (Homanics et al., 1999), and in light of the gowning evidence suggesting a role for
α-MSH and AgRP ethanol-related phenotypes (Kokare et al., 2008; Navarro et al., 2003,
2005, 2008, 2009; Ploj et al., 2002), it is tempting to speculate that the strain differences in
α-MSH and AgRP immunoreactivity contribute to the differences in neurobiological
responses to ethanol that are characteristically observed between C57BL/6J and 129/SvJ
mice. However, given that these peptides modulate a diverse set of neurobiological
functions, additional work is needed to determine if strain differences in α-MSH and AgRP
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contribute to C57BL/6J and 129/SvJ strain differences in neurobiological responses to
ethanol.
Previous research has shown that chronic exposure to ethanol significantly reduced (Navarro
et al., 2008), while abstinence following chronic ethanol exposure increased (Kokare et al.,
2008) endogenous α-MSH immunoreactivity in specific brain regions of Sprague-Dawley
rats. The absence of an effect of acute ethanol administration on α-MSH immunoreactivity
in the present work may suggest that ethanol-induced changes in α-MSH immunoreactivity
gradually emerge with chronic exposure. However, an acute i.p. injection of a 2.0 g/kg dose
of ethanol was reported to decrease α-MSH immunoreactivity in regions of the
hypothalamus and amygdala of rats (Kokare et al., 2008), raising the possibility that there
are species (mice vs. rats) differences in α-MSH immunoreactivity in response to acute
ethanol injections. However, it should be noted that in the rat study (Kokare et al., 2008),
animals injected with ethanol were compared with a group of rats that had consumed a
nutritionally balanced liquid diet (in place of food) for 15 days, which raises the possibility
that group differences in α-MSH immunoreactivity were related to factors other than acute
ethanol exposure, including differences in caloric intake and a host of other procedural
differences. Nonetheless, before ruling out a role for endogenous α-MSH in the modulation
ethanol's acute effects, further characterization is required (e.g., in other strains or species,
with additional doses of ethanol, following ethanol self-administration, and with other
techniques for assessing protein levels such as Western blotting).
One caveat that must be considered is that stress associated with i.p. injection of ethanol
produced nonspecific effects on α-MSH and/or AgRP immunoreactivity. In fact, stress
exposure increases α-MSH release into the blood-stream (Goudreau et al., 1993; Liu et al.,
2007) and blunts central AgRP signaling (Kas et al., 2005). While we did not observe
ethanol-induced alterations of α-MSH immunoreactivity, possible stress-induced increases
of α-MSH immunoreactivity may have masked the attenuating effects of ethanol on α-MSH
(Navarro et al., 2008). However, it is unlikely that the stress associated with ethanol
injections accounts for the strain differences observed with α-MSH immunoreactivity data
as there were no significant dose by strain interaction effects (that is, strain differences were
evident regardless of saline or ethanol treatment). Furthermore, since foot shock-induced
stress decreases AgRP mRNA in the ARC which is associated with evidence of blunted
AgRP release (Kas et al., 2005), ethanol-induced increases of AgRP immunoreactivity in the
ARC are likely not related to stress. Finally, while the effects of a ketamine/xylazine (K/X)
anesthetic on α-MSH or AgRP immunoreactivity have not been assessed, previous work has
revealed that rats anesthetized with K/X failed to show increased c-Fos immunoreactivity in
all but 1 brain region examined relative to awake rats when brains were collected 2 hours
after drug administration. Halothane anesthesia, on the other hand, induced elevations of c-
Fos immunoreactivity in all the 7 brain regions that were examined (Roda et al., 2004). In
light of these observations with c-Fos immunoreactivity, we believe that it is unlikely that K/
X administration influenced α-MSH or AgRP immunoreactivity in the present report.
In conclusion, the present report provides novel evidence that acute exposure to ethanol
induces a dose-dependent increase in AgRP immunoreactivity in the ARC of ethanol
preferring C57BL/6J mice, but not in moderate ethanol drinking 129/SvJ mice. This
observation suggests that endogenous AgRP signaling may contribute to some of the
differences in neurobiological responses to ethanol between these strains, including ethanol
consumption and/or ethanol-induced sedation. It will be important in future studies to
determine if excessive binge-like ethanol consumption in C57BL/6J mice also promotes
increases of AgRP immuno-reactivity. Finally, while previous work shows that changes of
endogenous α-MSH immunoreactivity are present following chronic ethanol exposure and
ethanol withdrawal, the current observations failed to show changes in α-MSH
Cubero et al. Page 8













immunoreactivity following acute ethanol administration. Taken together, an interesting
possibility is that changes in α-MSH signaling over the course of long-term ethanol
exposure contributes to ethanol dependence, whereas increases of AgRP signaling in
response to acute ethanol administration contributes to the immediate neurobiological
responses to ethanol, including those that modulate the reinforcing properties of ethanol and
binge-like drinking. Thus, compounds which target MCRs may prove to have therapeutic
value in the treatment excessive ethanol consumption and/or the symptoms associated with
ethanol dependence and withdrawal.
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Quantification of Agouti-related protein immunoreactivity (AgRP) (% area) in the arcuate
nucleus of the hypothalamus (ARC). 129/SvJ and C57BL/6J mice were given intraperitoneal
injection of isotonic saline or a 1.5 g/kg or 3.5 g/kg dose of ethanol, and brains were
collected 2 hours after injections. Values are represented as mean ± SEM. There are
statistical differences between groups that do not share overlapping lettering (a or b; p <
0.05).
Cubero et al. Page 13














Representative photomicrographs of 40 lm coronal sections showing Agouti-related protein
immunoreactivity through the arcuate nucleus of the hypothalamus (ARC) in 129/SvJ and
C57BL/6J mice that were given intraperitoneal injection of isotonic saline or a 1.5 g/kg or
3.5 g/kg dose of ethanol. Images were photographed at approximately −1.7 mm relative to
Bregma and quantified at a magnification of 40×. Scale bar = 50 μm.
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Quantification of α-melanocyte stimulating hormone (α-MSH) immunoreactivity (% area) in
the arcuate nucleus of the hypothalamus (ARC; A), the lateral nucleus of the hypothalamus
(LH; B), the dorsomedial nucleus of the hypothalamus (DMH; C), and the medial amygdala
(MA; D). 129/SvJ and C57BL/6J mice were given intraperitoneal injection of isotonic saline
or a 1.5 g/kg or 3.5 g/kg dose of ethanol, and brains were collected 2 hours after injections.
Values are represented as mean ± SEM.
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Representative photomicrographs of 40 μm coronal sections showing α-melanocyte
stimulating hormone (α-MSH) immunoreactivity through the arcuate nucleus of the
hypothalamus (ARC; A and E), the lateral nucleus of the hypothalamus (LH; B and F), the
dorsomedial nucleus of the hypothalamus (DMH; C and G), and the medial amygdala (MA;
D and H) in saline treated mice. Sections were collected from 129/SvJ (A–D) and C57BL/6J
(E–H)mice. Images were photographed and quantified at a magnification of 40×. Relative to
Bregma, photographs were taken at approximately −1.7 mm (ARC and DMH) and −1.34
mm (LH and MA). Scale bar = 50 μm.
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